135 related articles for article (PubMed ID: 38642961)
1. Persistent pulmonary abnormalities after 18 months of SARS-CoV-2 pneumonia.
Valenzuela C; de la Fuente L; Hernández S; Olivera MJ; Molina C; Montes N; Benavides C; Caballero P
Radiologia (Engl Ed); 2024 Apr; 66 Suppl 1():S47-S56. PubMed ID: 38642961
[TBL] [Abstract][Full Text] [Related]
2. One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study.
Faverio P; Luppi F; Rebora P; D'Andrea G; Stainer A; Busnelli S; Catalano M; Modafferi G; Franco G; Monzani A; Galimberti S; Scarpazza P; Oggionni E; Betti M; Oggionni T; De Giacomi F; Bini F; Bodini BD; Parati M; Bilucaglia L; Ceruti P; Modina D; Harari S; Caminati A; Intotero M; Sergio P; Monzillo G; Leati G; Borghesi A; Zompatori M; Corso R; Valsecchi MG; Bellani G; Foti G; Pesci A
Respir Res; 2022 Mar; 23(1):65. PubMed ID: 35313890
[TBL] [Abstract][Full Text] [Related]
3. Follow-Up Analysis of Pulmonary Function, Exercise Capacity, Radiological Changes, and Quality of Life Two Months after Recovery from SARS-CoV-2 Pneumonia.
Strumiliene E; Zeleckiene I; Bliudzius R; Samuilis A; Zvirblis T; Zablockiene B; Strumila A; Gruslys V; Malinauskiene L; Kasiulevicius V; Jancoriene L
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204878
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial.
Bazdyrev E; Panova M; Brachs M; Smolyarchuk E; Tsygankova D; Gofman L; Abdyusheva Y; Novikov F
J Transl Med; 2022 Nov; 20(1):506. PubMed ID: 36329513
[TBL] [Abstract][Full Text] [Related]
5. Impact of admission viral load on respiratory outcomes in hospitalized SARS-CoV-2 infected patients with cancer and without cancer: A 2-, 4- and 6-months follow-up prospective study.
Al-Mozaini M; Karim AR; Islam SS
J Infect Public Health; 2023 Aug; 16(8):1209-1219. PubMed ID: 37276715
[TBL] [Abstract][Full Text] [Related]
6. Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study.
Frija-Masson J; Debray MP; Boussouar S; Khalil A; Bancal C; Motiejunaite J; Galarza-Jimenez MA; Benzaquen H; Penaud D; Laveneziana P; Malrin R; Redheuil A; Donciu V; Lucidarme O; Taillé C; Guerder A; Arnoult F; Vidal-Petiot E; Flamant M; Similowski T; Morelot-Panzini C; Faure M; Lescure FX; Straus C; d'Ortho MP; Gonzalez-Bermejo J
Respir Med; 2021 Aug; 184():106435. PubMed ID: 34020126
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary sequelae of SARS-CoV-2 infection and factors associated with persistent abnormal lung function at six months after infection: Prospective cohort study.
Yazji B; Voduc N; Mulpuru S; Cowan J
PLoS One; 2022; 17(11):e0277624. PubMed ID: 36395158
[TBL] [Abstract][Full Text] [Related]
8. Follow-up evaluation of pulmonary function and computed tomography findings in chronic kidney disease patients after COVID-19 infection.
Jaturapisanukul S; Yuangtrakul N; Wangcharoenrung D; Kanchanarat K; Radeesri K; Maneerit J; Manomaipiboon A; Rojtangkom K; Ananthanalapa C; Rungrojthanakit S; Thinpangnga P; Alvior J; Trakarnvanich T
PLoS One; 2023; 18(8):e0286832. PubMed ID: 37582084
[TBL] [Abstract][Full Text] [Related]
9. High-Resolution CT Scan Fibrotic Patterns in Stage IV Pulmonary Sarcoidosis: Impact on Pulmonary Function and Survival.
Obi ON; Alqalyoobi S; Maddipati V; Lower EE; Baughman RP
Chest; 2024 Apr; 165(4):892-907. PubMed ID: 37879560
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary circulation abnormalities in post-acute COVID-19 syndrome: dual-energy CT angiographic findings in 79 patients.
Mohamed I; de Broucker V; Duhamel A; Giordano J; Ego A; Fonne N; Chenivesse C; Remy J; Remy-Jardin M
Eur Radiol; 2023 Jul; 33(7):4700-4712. PubMed ID: 37145145
[TBL] [Abstract][Full Text] [Related]
11. Primary SARS-CoV-2 Pneumonia Screening in Adults: Analysis of the Correlation Between High-Resolution Computed Tomography Pulmonary Patterns and Initial Oxygen Saturation Levels.
Alonazi B; Mostafa MA; Farghaly AM; Zindani SA; Al-Watban JA; Altaimi F; Almotairy AS; Fagiry MA; Mahmoud MZ
Curr Med Imaging; 2022; 19(5):486-493. PubMed ID: 35927895
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography findings as determinants of pulmonary function tests in fibrotic interstitial lung diseases-Network-analyses and multivariate models.
Lang D; Akbari K; Walcherberger S; Hergan B; Horner A; Hepp M; Kaiser B; Pieringer H; Lamprecht B
Chron Respir Dis; 2020; 17():1479973120967025. PubMed ID: 33272023
[TBL] [Abstract][Full Text] [Related]
13. Association of abnormal pulmonary vasculature on CT scan for COVID-19 infection with decreased diffusion capacity in follow up: A retrospective cohort study.
Salerno D; Oriaku I; Darnell M; Lanclus M; De Backer J; Lavon B; Gupta R; Jaffe F; Vega Sanchez ME; Kim V;
PLoS One; 2021; 16(10):e0257892. PubMed ID: 34653196
[TBL] [Abstract][Full Text] [Related]
14. Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months.
Steinbeis F; Thibeault C; Doellinger F; Ring RM; Mittermaier M; Ruwwe-Glösenkamp C; Alius F; Knape P; Meyer HJ; Lippert LJ; Helbig ET; Grund D; Temmesfeld-Wollbrück B; Suttorp N; Sander LE; Kurth F; Penzkofer T; Witzenrath M; Zoller T
Respir Med; 2022 Jan; 191():106709. PubMed ID: 34871947
[TBL] [Abstract][Full Text] [Related]
15. Severe SARS-CoV-2 pneumonia: Clinical, functional and imaging outcomes at 4 months.
Noel-Savina E; Viatgé T; Faviez G; Lepage B; Mhanna LT; Pontier S; Dupuis M; Collot S; Thomas P; Idoate Lacasia J; Crognier L; Bouharaoua S; Silva Sifontes S; Mazieres J; Prévot G; Didier A
Respir Med Res; 2021 Nov; 80():100822. PubMed ID: 34242974
[TBL] [Abstract][Full Text] [Related]
16. A prospective evaluation of lung function at three and six months in patients with previous SARS-COV-2 pneumonia.
Orzes N; Pini L; Levi G; Uccelli S; Cettolo F; Tantucci C
Respir Med; 2021 Sep; 186():106541. PubMed ID: 34280885
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis.
Mori S; Cho I; Koga Y; Sugimoto M
J Rheumatol; 2008 Aug; 35(8):1513-21. PubMed ID: 18597412
[TBL] [Abstract][Full Text] [Related]
18. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.
Wu X; Liu X; Zhou Y; Yu H; Li R; Zhan Q; Ni F; Fang S; Lu Y; Ding X; Liu H; Ewing RM; Jones MG; Hu Y; Nie H; Wang Y
Lancet Respir Med; 2021 Jul; 9(7):747-754. PubMed ID: 33964245
[TBL] [Abstract][Full Text] [Related]
19. Assessment of interstitial lung disease in systemic sclerosis using the quantitative CT algorithm CALIPER.
Ferrazza AM; Gigante A; Gasperini ML; Ammendola RM; Paone G; Carbone I; Rosato E
Clin Rheumatol; 2020 May; 39(5):1537-1542. PubMed ID: 31940114
[TBL] [Abstract][Full Text] [Related]
20. Persistence of post-COVID lung parenchymal abnormalities during the three-month follow-up.
Zubairi ABS; Shaikh A; Zubair SM; Ali AS; Awan S; Irfan M
Adv Respir Med; 2021; 89(5):477-483. PubMed ID: 34612504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
